Heparin and Enoxaparin Enhance Endotoxin-Induced Tumor Necrosis Factor-α Production in Human Monocytes
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 229 (4) , 542-550
- https://doi.org/10.1097/00000658-199904000-00014
Abstract
To determine whether heparin or the low-molecular-weight heparin enoxaparin alter lipopolysaccharide (LPS)-induced monocyte activation. Heparin is widely used in clinical practice to inhibit the coagulation cascade. However, heparin also is a naturally occurring glucosaminoglycan and a pleiotropic immunomodulator that binds to a variety of proteins. LPS is a component of gram-negative bacteria and is thought to be responsible for many of the deleterious effects seen in sepsis. The binding of LPS to CD14 induces a signaling cascade that results in the release of many inflammatory mediators, including tumor necrosis factor-alpha (TNF-alpha). Monocytes from healthy volunteers were isolated and cultured in the presence of saline, LPS (10 ng/ml), heparin (0.1 to 1000 microg/ml), or enoxaparin (0.1 to 1000 microg/ml). In blocking experiments, cells were pretreated for 60 minutes with the monoclonal anti-CD14 antibody MY4 (10 microg/ml) or with isotype-matched control IgG2 (10 microg/ml). TNF-alpha values were measured with enzyme-linked immunosorbent assay. Significance was assessed with analysis of variance. Heparin (10 to 1000 microg/ml) and enoxaparin (1000 microg/ml) significantly enhanced LPS-induced TNF-alpha release. Heparin (1000 microg/ml) or enoxaparin (1000 microg/ml) did not produce TNF-alpha in the absence of LPS. Blockade of CD14 abrogated both LPS-induced TNF-alpha release and the effect of heparin or enoxaparin to enhance LPS-induced TNF-alpha release. The effect of heparin to enhance LPS-induced TNF-alpha release is a biologic phenomenon that reveals a novel and potentially important host defense mechanism during endotoxemia and sepsis. Binding of LPS to CD14 is necessary to induce this phenomenon, suggesting that both heparin and enoxaparin induce signaling mechanisms that are downstream from the initial binding of LPS on CD14.Keywords
This publication has 74 references indexed in Scilit:
- CD14 Expression in Injured Patients Correlates with OutcomeAnnals of Surgery, 1996
- Carbohydrate-Protein Interactions in Vascular BiologyAnnual Review of Cell and Developmental Biology, 1995
- Interleukin-10Annual Review of Immunology, 1993
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- PROTEOGLYCANS: STRUCTURES AND INTERACTIONSAnnual Review of Biochemistry, 1991
- Structure and Function of Lipopolysaccharide Binding ProteinScience, 1990
- Heparin, A Potent Releasing Agent of Extracellular Superoxide Dismutase (EC-SOD C), Suppresses Ischaemic Paw Oedema in MiceFree Radical Research Communications, 1990
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989
- Comparative Study on the in vitro and in vivo Activities of Seven Low-Molecular-Weight HeparinsPathophysiology of Haemostasis and Thrombosis, 1988
- Some Recent Developments in the Pharmacology of HeparinThe Journal of Clinical Pharmacology, 1979